Press Release

PathoQuest Appoints Colette Côté as Chief Portfolio Officer and General Manager of the Company’s U.S. Subsidiary
PathoQuest Appoints Colette Côté as Chief Portfolio Officer and General Manager of the Company’s U.S. Subsidiary

Annoucement of the appointment of Colette Côté, Ph.D. as Chief Portfolio Officer and General Manager of PathoQuest’s U.S. subsidiary located in Wayne, PA. Ms. Côté’s expertise and long history of innovating, developing, and applying tailored NGS-based assays to the biopharma biosafety testing space will further drive the expansion and growth of PathoQuest’s NGS-based services portfolio within the North American market.

read more
PathoQuest signs agreement with MIT to join CAACB as NGS viral safety expert
PathoQuest signs agreement with MIT to join CAACB as NGS viral safety expert

PathoQuest announced that it has signed an agreement with the MIT to join the CAACB as an associate member. PathoQuest brings its 10-year experience in viral safety testing and quality control of biologics to contribute to research programs to help mitigate the risk of adventitious agent contamination in biopharmaceutical manufacturing. This collaboration is expected to translate into practical advances in this field and accelerate the adoption of NGS for the viral safety testing of biologics.

read more
Viral Safety Expert, Audrey Brussel, joins PathoQuest
Viral Safety Expert, Audrey Brussel, joins PathoQuest

PathoQuest announces the appointment of Audrey Brussel, Ph.D. to the newly created position of Viral Safety Leader. Her addition to the company will strengthen PathoQuest’s in-house expertise in viral safety. Her insights and knowledge of the pharmaceutical industry from a customer’s perspective will help deliver a better service and support the growth of the company’s rapidly expanding quality control testing business for biologics.

read more

Click here to learn more about PathoQuest’s Biologics Genomic Service for biopharmaceutical companies.

Connect